| Field | Specification |
|---|---|
| Mfr No | |
| Assay Time | |
| Detection Method | |
| Product Type | |
| Sample Type(s) | Urea in biological samples (e.g. plasma, serum, urine) and food/beverage samples (e.g. milk) |
| Shipping | |
| Species | |
| Storage |
Overview
For quantitative enzymatic determination of urea. The assay uses OD557nm for signal readout. Compatible sample input includes Urea in biological samples (e.g. plasma, serum, urine) and food/beverage samples (e.g. milk). Typical stated assay timing is 5 min.
Key elements and design rationale
- Readout format: OD557nm supports plate-based signal acquisition and consistent comparison across matched samples.
- Sample compatibility: The stated sample scope includes Urea in biological samples (e.g. plasma, serum, urine) and food/beverage samples (e.g. milk), which is useful when aligning matrix type with calibration and control design.
- Analytical range context: The supplied specifications include a stated detection limit of 1 mg/mL (0.17 mM) for interpreting low-signal samples.
- Feature emphasis: Fast and sensitive. Linear detection range (20 µL sample): 1 mg/mL (0.17 mM) to 100 mg/mL (17 mM) urea in a 96-well plate assay.
Additional feature notes highlight Convenient. The procedure involves adding a single working reagent and reading the absorbance after 5 minutes. Room temperature assay. No 37°C heater is needed; High-throughput. Homogeneous “mix-incubate-measure” type assay.Can be readily automated as a high-throughput 96-well plate assay for thousands of samples per day. Available format information for this listing includes 100 Tests.
Biological background
This product is centered on measurement of urea within the matrices described for the assay. In practice, datasets from this type of format are typically interpreted by comparing relative signal, activity, or abundance across matched control and experimental groups rather than relying on a single value in isolation. Careful alignment of sample matrix, incubation window, and calibration strategy is important when comparing results across plates, operators, or study days.
More details
UREA, the major end product of protein catabolism in animals, is primarily produced in the liver and secreted by the kidneys. It is the primary vehicle for the removal of toxic ammonia from the body. Urea determination is very useful for medical clinicians to assess the kidney function of patients. In general, increased urea levels are associated with nephritis, renal ischemia, urinary tract obstruction, and certain extrarenal diseases (e.g. congestive heart failure, liver diseases, and diabetes). Decreased levels often indicate acute hepatic insufficiency, but may also result from over-vigorous parenteral fluid therapy.BioAssay Systems colorimetric urea (BUN) assay is based on urease catalyzed conversion of urea to ammonium and carbon dioxide. The pH of the reaction medium is monitored by a chromogen and the intensity of the reaction product at 557 nm is directly proportional to the urea concentration in the sample.
Detection method
Colorimetric (OD 557 nm).
Detection limit and analytical sensitivity
Reported detection limit: 1 mg/mL (0.17 mM).
Procedures and timing
Stated procedure or timing information: 5 min.
Research relevance and current trends
- Plate-based quantification and side-by-side group comparison remain central use cases for this assay format.
- The product notes emphasize multi-sample throughput, making it relevant for screening-oriented and larger batch comparison studies.
- Short assay timing and plate compatibility support time-course or repeated-measure collection plans when handling is kept consistent.
Common research applications
- Quantify urea in urea in biological samples (plasma, serum by OD557 nm readout.
- Compare treatment or phenotype groups using matched urea in biological samples (plasma, serum handling.
- Monitor time-course or pre/post changes in urea in biological samples (plasma, serum across study conditions.
Interpretation is usually strongest when signal changes are assessed alongside matrix-matched controls, replicate agreement, and the assay's stated analytical window.
Notes for experimental interpretation
- Matrix composition, background signal, and sample handling can influence apparent response; compare like-with-like whenever possible.
- Use appropriate blanks, controls, and replicate wells to distinguish biological differences from plate, reagent, or handling variability.
How do I store the kit?
This kit is shipped at room temperature. Upon receiving, please store the Reagent and Standard in the refrigerator (4°C) and the Urease at -20°C to 4°C. For long term storage, keep the standard at -20°C.
There is a standard curve shown on the datasheet, why do I not construct one?
Yes, there is a standard curve in the datasheet; we include this to show the linear detection range of the kit for quantifying urea. Due to interference, an internal standard must be run for most samples. The datasheet has detailed information on how to perform this and calculate urea concentration from it.
I would like to construct a standard curve, how can I go about that?
If you wish to construct a standard curve, you may dilute the urea standard in dH2O and follow the instructions from question 4 below.
How can I detect urea in urine samples?
Please refer to DUR2-100 Urine Detection Protocol.
Can I store unused reagents for future use?
Yes, unused reagents can be stored according to the assay protocol.
I am not obtaining consistent data, what could be the problem?
This assay is pH dependent; therefore, temperature can affect the results. Be sure to equilibrate all components to room temperature before each assay.
For laboratories requiring additional technical capacity, we provide scientific support services including assay execution, method guidance, product sourcing, and customization to align the assay with specific experimental objectives. If you need assistance selecting the appropriate kit configuration, adapting the workflow to your application, or identifying related research services, please click Talk to a Scientist, email support@biohippo.com, or review our Research Services; a member of our scientific team will follow up with recommendations tailored to your study.
Effect of chronic kidney disease on hepatic clearance of drugs in rats
Tokunaga, A.,et al (2020). Effect of chronic kidney disease on hepatic clearance of drugs in rats. Biological & Pharmaceutical Bulletin, 43(9), 1324-1330. Assay: Urea in rat serum.
Epigallocatechin-3-gallate decreases the transport and metabolism of simvastatin in rats
Yang, W.,et al (2017). Epigallocatechin-3-gallate decreases the transport and metabolism of simvastatin in rats. Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 47(1), 86-92. Assay: Urea in rat plasma.